Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"
Year: 2025
Type: article
Abstract: I read with interest the subgroup analysis of the ARTESiA trial recently published in Lancet Neurology....
Author: Vittorio Pengo
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4409482002